Skip to main content

Advertisement

SpringerLink
Log in

Living therapeutics: Scientists genetically modify bacteria to deliver drugs

  • News
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A Correction to this article was published on 07 March 2017

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Change history

  • 15 February 2017

    In the January 2017 issue, the piece “Living therapeutics: Scientists genetically modify bacteria to deliver drugs” (Nat. Med. 23, 5–7, 2017) incorrectly stated that the company Oragenics is slated to launch a phase 2 trial on ulcerative mucositis next year. In fact, they will begin the trial in 2017. The error has been corrected in the HTML and PDF versions of this article.

References

  1. Joint United Nations Programme on HIV/AIDS. 2004 report on the global AIDS epidemic. (4th global report) 1–236 (UNAIDS, Geneva, 2004).

  2. Steidler, L. Antonie Van Leeuwenhoek 82, 323–331 (2002).

    Article  CAS  Google Scholar 

  3. Steidler, L. et al. Nat. Biotechnol. 21, 785–789 (2003).

    Article  CAS  Google Scholar 

  4. Vandenbroucke, K. et al. Mucosal Immunol. 3, 49–56 (2010).

    Article  CAS  Google Scholar 

  5. Limaye, S.A. et al. Cancer 119, 4268–4276 (2013).

    Article  CAS  Google Scholar 

  6. Langenaur, L.A. et al. Mucosal Immunol. 4, 648–657 (2011).

    Article  Google Scholar 

  7. Roberts, N.J. et al. Sci. Transl. Med. 6, 249ra111 (2014).

    Article  Google Scholar 

  8. Quintero, D., Carrafa, J., Vincent, L. & Bermudes, D. Biotechnol. Bioeng. 113, 2698–2711 (2016).

    Article  CAS  Google Scholar 

  9. Paton, A.W., Morona, R. & Paton, J.C. et al. Nat. Rev. Microbiol. 4, 193–200 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Amy Maxmen is a freelance science journalist based in Berkeley, California.,

    Amy Maxmen

Authors
  1. Amy Maxmen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maxmen, A. Living therapeutics: Scientists genetically modify bacteria to deliver drugs. Nat Med 23, 5–7 (2017). https://doi.org/10.1038/nm0117-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0117-5

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation